Answers are grounded in this paper and cite their sources.
Flavonoids, a broad class of polyphenolic secondary metabolites, possess diverse and potent biological activities, including anti-inflammatory, antioxidative, antiviral, and analgesic properties. Flavanones, a prominent flavonoid subclass, are especially notable for their therapeutic potential, with several derivatives exhibiting anticancer and antiviral effects. Bromination is a valuable strategy in drug development, as halogenation can enhance biological activity and provide synthetic handles for further molecular elaboration. While aromatic bromination of flavonoids is known, selective α-bromination of flavanones, particularly those bearing hydroxy and alkoxy substituents, remains underexplored due to electronic and oxidative challenges. In this study, we investigated the selective α-bromination of hydroxy- and alkoxy-substituted flavanones, generating novel brominated derivatives. We identified a mild, green protocol for α-bromination of a range of monosubstituted flavanones in good yields using copper-(II) bromide in ethyl acetate. The α-bromination of flavanones bearing multiple hydroxyl groups resulted in poor selectivity and competing nuclear bromination, underscoring the challenges posed by increased aromatic nucleophilicity. Novel products were characterized using a combination of nuclear magnetic resonance (NMR) spectroscopy, high-resolution mass spectrometry (HRMS), tandem electrospray ionization mass spectrometry (ESI-MS/MS), and X-ray crystallography. These findings expand the chemical space of flavanone derivatives and provide valuable intermediates for the synthesis of pharmacologically relevant heterocycles.
No takes yet. Share an insight, caveat, or question.
Sigmon et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: